Similar to those in MSCs, the concentrations of NAC used in precursor cells range from 500 M to 10 mM
When injection site reactions significantly impact treatment adherence, discussing alternative GLP-1 options with healthcare providers represents a reasonable approach, as therapeutic efficacy across the class often allows successful substitution while maintaining glycemic control or weight management benefits
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are pregnant, nursing, managing a health condition, or taking any medication, speak with a clinician first
Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR et al
Remember that decisions about GLP-1 therapy should be made collaboratively, considering your individual circumstances, preferences, and the latest available evidence